Preview | Company (Stock code) | Date/time | Event | Presenter |
---|---|---|---|---|
![]() | SCANCELL HOLDINGS (SCLP) | Fri, 31 Jul 2015 08:45 am (UK time) | General update and collaboration with ImmunID |
![]() |
![]() | SCANCELL HOLDINGS (SCLP) | Tue, 02 Jun 2015 07:10 am (UK time) | Scancell - Update on SCIB1 data |
![]() |
![]() | SCANCELL HOLDINGS (SCLP) | Tue, 24 Mar 2015 02:20 pm (UK time) | Scancell Holdings - SCIB2 also shown to synergise with checkpoint inhibitor blockade |
![]() |
![]() | SCANCELL HOLDINGS (SCLP) | Thu, 11 Dec 2014 03:00 pm (UK time) | Scancell Holdings - Analyst Interview, Panmure Gordon |
![]() |
![]() | SCANCELL HOLDINGS (SCLP) | Wed, 10 Dec 2014 09:00 am (UK time) | Scancell Holdings - Half yearly report |
![]() |
![]() | SCANCELL HOLDINGS (SCLP) | Wed, 13 Aug 2014 10:00 pm (UK time) | Scancell Holdings - Synergy of SCIB1 with checkpoint inhibitors |
![]() |
![]() | SCANCELL HOLDINGS (SCLP) | Sun, 08 Jun 2014 10:40 pm (UK time) | Scancell Holdings - SCIB1 Phase 1/2 clinical trial results presented at ASCO and DNA ImmunoBody patent granted in United States |
![]() |